Valeant Pharmaceuticals will pay about $1 billion to buy Sprout Pharmaceuticals, the maker of the first prescription drug designed to boost sexual desire in women. The deal Thursday comes one day after regulators approved the pill. Valeant expects the Sprout pill, Addyi, to be available in the United States in the fourth quarter.Read more on NewsOK.com